PT70571A - Process for the preparation of imidazole derivatives - Google Patents

Process for the preparation of imidazole derivatives

Info

Publication number
PT70571A
PT70571A PT70571A PT7057179A PT70571A PT 70571 A PT70571 A PT 70571A PT 70571 A PT70571 A PT 70571A PT 7057179 A PT7057179 A PT 7057179A PT 70571 A PT70571 A PT 70571A
Authority
PT
Portugal
Prior art keywords
preparation
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
PT70571A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10501705&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT70571(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of PT70571A publication Critical patent/PT70571A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT70571A 1978-12-13 1979-12-11 Process for the preparation of imidazole derivatives PT70571A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7848367 1978-12-13

Publications (1)

Publication Number Publication Date
PT70571A true PT70571A (en) 1980-01-01

Family

ID=10501705

Family Applications (1)

Application Number Title Priority Date Filing Date
PT70571A PT70571A (en) 1978-12-13 1979-12-11 Process for the preparation of imidazole derivatives

Country Status (34)

Country Link
US (2) US4602016A (pt)
JP (1) JPS585197B2 (pt)
KR (1) KR830001243B1 (pt)
AR (1) AR227637A1 (pt)
AT (1) AT373879B (pt)
AU (1) AU517892B2 (pt)
BE (1) BE880584A (pt)
CA (1) CA1108137A (pt)
CH (1) CH644597A5 (pt)
CS (1) CS216517B2 (pt)
DD (1) DD147943A5 (pt)
DE (1) DE2950019A1 (pt)
DK (1) DK471479A (pt)
EG (1) EG14227A (pt)
ES (1) ES8101556A1 (pt)
FI (1) FI70888C (pt)
FR (1) FR2444031A1 (pt)
GB (1) GB2038821B (pt)
GR (1) GR73003B (pt)
HU (1) HU183016B (pt)
IE (1) IE49318B1 (pt)
IL (1) IL58917A (pt)
IT (1) IT1194900B (pt)
LU (1) LU81985A1 (pt)
NL (1) NL177749C (pt)
NO (1) NO153135C (pt)
NZ (1) NZ192360A (pt)
PH (1) PH15056A (pt)
PL (1) PL134005B1 (pt)
PT (1) PT70571A (pt)
SE (1) SE444937B (pt)
SU (1) SU878195A3 (pt)
YU (1) YU301879A (pt)
ZA (1) ZA796708B (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350696A (en) * 1980-03-08 1982-09-21 Pfizer Inc. Imidazole derivatives, process for their preparation and pharmaceutical compositions thereof
US4444775A (en) * 1981-06-22 1984-04-24 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridines
DE3148291A1 (de) * 1981-12-05 1983-06-09 Basf Ag, 6700 Ludwigshafen Harnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
JPS58113178A (ja) * 1981-12-28 1983-07-05 Yamanouchi Pharmaceut Co Ltd 「お」−（１−イミダゾリル）アルキルオキシ（またはチオ）ベンゼン誘導体
US4470986A (en) * 1982-12-21 1984-09-11 Ciba-Geigy Corporation Certain imidazo (1,5-A) pyridine aliphatic carboxylic acid derivatives and their use as selective thromboxane inhibitors
US4588732A (en) * 1982-12-21 1986-05-13 Ciba-Geigy Corporation Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors
NL8301550A (nl) * 1983-05-03 1984-12-03 Gist Brocades Nv Imidazolethanol esters.
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
IT1212791B (it) * 1983-11-24 1989-11-30 Medea Res Srl Derivato imidazolico adattivita' vasodilatatrice ed antitrombotica, sua preparazione e composizioni farmaceutiche che lo contengono.
ES8601148A1 (es) * 1984-12-10 1985-11-16 Ferrer Int Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
JPH0625141B2 (ja) * 1985-01-16 1994-04-06 三共株式会社 イミダゾ−ル誘導体およびその製法
US4847272A (en) 1986-01-28 1989-07-11 Sankyo Company Limited Thianaphthene derivatives
EP0239306B1 (en) 1986-03-27 1993-06-02 Merck Frosst Canada Inc. Tetrahydrocarbazole esters
JPS63179840A (ja) * 1986-07-24 1988-07-23 Yamanouchi Pharmaceut Co Ltd 新規化学物質
EP0284892B1 (de) * 1987-04-03 1990-10-31 Cl Pharma Aktiengesellschaft Neue 2-Thienyloxyessigsäurederivate, ein Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
JPH01125372A (ja) * 1988-09-12 1989-05-17 Yamanouchi Pharmaceut Co Ltd イミダゾリルアルキルオキシベンゼン誘導体
DE4204686A1 (de) * 1992-02-17 1993-08-19 Gruenenthal Gmbh Imidazolylphenolderivate, diese enthaltende arzneimittel sowie ein verfahren zur herstellung dieser verbindungen und arzneimitteln
WO1999045905A2 (en) * 1998-03-13 1999-09-16 Pozen Inc. Prophylaxis and treatment of migraine headaches with thromboxane synthetase inhibitors and/or receptor antagonists
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
JP2005533830A (ja) * 2002-07-09 2005-11-10 ビー．エム．アール．エイ． コーポレイション ベスローテン フェンノートシャップ トロンボキサンａ２受容体アンタゴニストおよびｃｏｘ−２阻害剤の薬剤の組み合わせ
EP1660076A1 (en) * 2003-08-07 2006-05-31 B.M.R.A. Corporation B.V. Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxigenase-1
KR101275814B1 (ko) * 2006-06-23 2013-06-18 삼성에스디아이 주식회사 분산제 화합물 및 그의 제조방법
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN101811974B (zh) * 2010-04-15 2012-12-12 合肥医工医药有限公司 4-(3-(二甲氨基)丙氧基)-3,5-二甲氧基苯甲酸、其制法及医药用途
CN101851209B (zh) * 2010-06-21 2012-09-19 合肥医工医药有限公司 咪唑乙基香草酸醚、其制备方法及其医药用途
MX2014014234A (es) * 2012-05-22 2015-05-07 Genentech Inc Benzamidas n-sustituidas y su uso en el tratamiento del dolor.
WO2014066491A1 (en) 2012-10-26 2014-05-01 Merck Sharp & Dohme Corp. N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels
WO2023240378A1 (zh) * 2022-06-13 2023-12-21 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途
CN114736161B (zh) * 2022-06-13 2022-09-13 南京医工医药技术有限公司 咪唑烷基香草酸醚衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534061A (en) * 1967-12-04 1970-10-13 Parke Davis & Co N-(alpha-(p-methoxyphenyl)-beta-nitrostyryl)-phenoxyalkyl pyrroles
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
GB2038821A (en) 1980-07-30
FR2444031B1 (pt) 1983-06-10
GB2038821B (en) 1982-12-08
LU81985A1 (fr) 1980-04-22
NL177749B (nl) 1985-06-17
ATA783379A (de) 1983-07-15
KR830001243B1 (ko) 1983-06-27
ES486782A0 (es) 1980-12-16
IL58917A (en) 1984-03-30
FR2444031A1 (fr) 1980-07-11
ES8101556A1 (es) 1980-12-16
HU183016B (en) 1984-04-28
DE2950019A1 (de) 1980-07-10
JPS5585572A (en) 1980-06-27
US4636500A (en) 1987-01-13
AT373879B (de) 1984-02-27
AR227637A1 (es) 1982-11-30
NZ192360A (en) 1982-02-23
DD147943A5 (de) 1981-04-29
PL220351A1 (pt) 1980-12-01
AU517892B2 (en) 1981-09-03
IT7941669A0 (it) 1979-12-11
BE880584A (fr) 1980-06-12
IL58917A0 (en) 1980-03-31
SE7910204L (sv) 1980-06-14
NL7908899A (nl) 1980-06-17
AU5372579A (en) 1980-06-19
NO794069L (no) 1980-06-16
YU301879A (en) 1983-01-21
IT1194900B (it) 1988-09-28
IE49318B1 (en) 1985-09-18
ZA796708B (en) 1981-08-26
PL134005B1 (en) 1985-07-31
IE792403L (en) 1980-06-13
JPS585197B2 (ja) 1983-01-29
SU878195A3 (ru) 1981-10-30
EG14227A (en) 1983-12-31
NL177749C (nl) 1985-11-18
CA1108137A (en) 1981-09-01
NO153135B (no) 1985-10-14
CS216517B2 (en) 1982-11-26
GR73003B (pt) 1984-01-24
SE444937B (sv) 1986-05-20
FI793868A (fi) 1980-06-14
CH644597A5 (de) 1984-08-15
FI70888C (fi) 1986-10-27
PH15056A (en) 1982-06-03
KR830001242A (ko) 1983-04-29
US4602016A (en) 1986-07-22
DK471479A (da) 1980-06-14
NO153135C (no) 1986-01-22
FI70888B (fi) 1986-07-18

Similar Documents

Publication Publication Date Title
PT70571A (en) Process for the preparation of imidazole derivatives
RO83052B (ro) Procedeu pentru prepararea unor derivati de fenetanolamina
DE2964427D1 (en) Process for the preparation of furanyl-benzazoles
DE2966723D1 (en) Process for the preparation of 6-amino-6-desoxy-l-sorbose
YU177879A (en) Process for obtaining imidazole derivatives
DE2960108D1 (en) Process for the preparation of glyoxal
HRP970093B1 (en) Process for the preparation of imidazolylvinylethers
DE2960539D1 (en) Process for the preparation of 4-fluor-3-phenoxytoluene
IL57539A0 (en) Process for the preparation of 0-methoallyl-oxyphenol
DE2963068D1 (en) Process for the preparation of benzothiazole-disulphide
DE2964389D1 (en) Process for the preparation of 2-imidazolines
DE2961140D1 (en) Process for the preparation of azaspirodecanes
DE2961237D1 (en) Process for the preparation of hydroxyalkyl-perfluoralkane-sulfonamides
GB2027014B (en) Process for the preparation of 5-halo-6,9 -oxido-prostaglandin derivatives
DE2960278D1 (en) Process for the preparation of 4-acyloxy-2-methylcrotonaldehydes
KE3399A (en) Process for the preparation of 1-n-acyl-aminoglycosides
DE2960541D1 (en) Process for the preparation of 3-phenoxybenzaldehydes
GB2015998B (en) Process for the preparation of p-amino-diphenylamine
DE2962108D1 (en) Process for the preparation of 4-methyl-2-amino-benzothiazole
DE2961447D1 (en) Process for the preparation of p-nitroso-diphenylhydroxylamines
DE2961888D1 (en) Process for the preparation of 6-hydroxypyrid-2-ones
GB2088852B (en) Process for the preparation of 9-oxobenzomorphans
DE2860555D1 (en) Process for the preparation of 4-methyl-5-chloromethyl-imidazole
DE2964895D1 (en) Process for the preparation of isopropylamino-2-pyrimidine
DE2961975D1 (en) Process for the preparation of 5-diethylamino-2-pentanol